NEW DELHI, July 30 -- During a discussion on Operation Sindoor in the Rajya Sabha, Defence Minister Rajnath Singh declared that the Indian Armed Forces had successfully achieved all their strategic ob... Read More
Dhaka, July 30 -- Three of the country's major political forces-Jamaat-e-Islami, the National Citizen Party (NCP), and Islami Andolan Bangladesh (IAB) have outright rejected the draft of the proposed ... Read More
Dhaka, July 30 -- National Citizen Party (NCP) Convener Nahid Islam has pledged to eradicate "Mujibism" from every part of Bangladesh, stating that those who uphold the ideology will be held accountab... Read More
Chad, Juillet 30 -- Le Tchad, pays sahélien souvent perçu à travers le prisme des urgences climatiques et humanitaires, fait aujourd’hui une entrée dans la dynamique continentale de l’économie circula... Read More
Chad, Juillet 30 -- Le Forum politique de haut niveau s'est tenu du 14 au 23 juillet 2025, sous l'égide du Conseil économique et social des Nations-Unies. Des responsables gouvernementaux, des dirigea... Read More
Chad, Juillet 30 -- Le Conseil d'administration du Groupe de la Banque africaine de développement a approuvé un don de 19,93 millions de dollars américains à la Gambie pour mettre en œuvre le Projet d... Read More
Jammu, July 30 -- BJP National General Secretary Tarun Chugh on Wednesday launched a scathing attack on Chief Minister Omar Abdullah, saying his government failed to deliver on promises made to the pe... Read More
Srinagar, July 30 -- More than 120 prominent individuals including former bureaucrats, diplomats, journalists, academicians, and civil society members have jointly called on Members of Parliament to p... Read More
Chad, Juillet 30 -- Avant, l’usine tournait au fioul lourd. La fumée noire étouffait le voisinage, les machines s’encrassaient, et le démarrage des chaudières prenait un temps précieux. Aujourd’hui, g... Read More
Singapore, July 30 -- Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialising potential best-in-class medicines for serious and rare d... Read More